Related Experiment Video
Updated: Jun 19, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Genetic association of diabetic retinopathy with long noncoding RNA CDKN2B-AS1 gene polymorphism
Yen-Po Yao1,2, Hsiang-Wen Chien3,4,5,6, Kai Wang3,4,5
1Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Aim:
We attempted to test the influences of cyclin dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) gene polymorphisms on the susceptibility to Diabetic retinopathy (DR).
Methods:
Five single-nucleotide polymorphisms (SNPs) of the CDKN2B-AS1 gene, rs564398, rs1333048, rs1537373, rs2151280, and rs8181047 were examined in 280 DR cases and 455 DR-free diabetic controls.
Results:
Among these loci tested, we demonstrated that diabetic carriers of at least one polymorphic allele (G) of rs2151280 (AG and GG; AOR, 1.613; 95% CI, 1.040-2.501; p = 0.033) are more susceptible to proliferative DR but not non-proliferative DR. This genetic association with the risk of developing proliferative DR was further strengthened in homozygotes for the polymorphic allele (G) of rs2151280 (GG; AOR, 2.194; 95% CI, 1.117-4.308; p = 0.023). We detected a significant association of the polymorphic allele (G) of rs2151280 with proliferative DR patients (OR, 1.503; 95% CI, 1.112-2.033; p = 0.008) but not with the entire DR or non-proliferative DR group. Moreover, as compared to those who do not possess the polymorphic allele of rs2151280 (AA), DR patients carrying at least one polymorphic allele of rs2151280 (AG + GG) exhibited a lower glomerular filtration rate and HDL cholesterol level, revealing a promotive role of rs2151280 in renal and cardiovascular complications of diabetes.
Conclusion:
Taken together, our findings implicate an impact of CDKN2B-AS1 gene polymorphisms on the progression of DR.
Insights
Genetic variations in the CDKN2B-AS1 gene, specifically the rs2151280 polymorphism, increase susceptibility to proliferative diabetic retinopathy (DR). This genetic factor also correlates with poorer kidney function and lower HDL cholesterol in DR patients.
Area of Science:
- Genetics
- Ophthalmology
- Endocrinology
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss in diabetic patients.
- The genetic underpinnings of DR susceptibility require further elucidation.
- The cyclin dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) gene is a potential candidate for influencing DR risk.
Purpose of the Study:
- To investigate the association between specific single-nucleotide polymorphisms (SNPs) in the CDKN2B-AS1 gene and the risk of developing diabetic retinopathy.
- To determine if CDKN2B-AS1 gene polymorphisms influence the progression of DR to its proliferative form.
- To explore the potential impact of these genetic variations on renal and cardiovascular complications in diabetic patients with DR.
Main Methods:
- Genotyping of five CDKN2B-AS1 SNPs (rs564398, rs1333048, rs1537373, rs2151280, rs8181047) was performed.
- A case-control study design was employed, including 280 DR patients and 455 diabetic controls without DR.
- Statistical analyses, including odds ratios (AOR) and confidence intervals (CI), were used to assess genetic associations.
Main Results:
- The rs2151280 polymorphism in the CDKN2B-AS1 gene was significantly associated with an increased susceptibility to proliferative DR (AG/GG genotypes; AOR=1.613, p=0.033).
- This association was more pronounced in individuals with the homozygous GG genotype for rs2151280 (AOR=2.194, p=0.023).
- DR patients with the rs2151280 polymorphic allele (AG/GG) exhibited lower glomerular filtration rate and HDL cholesterol levels compared to non-polymorphic allele carriers (AA).
Conclusions:
- Findings suggest that CDKN2B-AS1 gene polymorphisms, particularly rs2151280, play a role in the progression of diabetic retinopathy.
- The rs2151280 polymorphism may also contribute to renal and cardiovascular complications in diabetic patients.
- CDKN2B-AS1 gene variations represent a potential genetic marker for DR risk and associated comorbidities.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Non-LTR Retrotransposons

